[go: up one dir, main page]

FI883735L - FRAMSTAELLNING AV ANTIGENER AV MAENNISKANS IMMUNBRISTSJUKDOM, TYP 1, OCH DERAS ANVAENDNING SOM DIAGNOSTIKA OCH THERAPEUTIC MEDEL. - Google Patents

FRAMSTAELLNING AV ANTIGENER AV MAENNISKANS IMMUNBRISTSJUKDOM, TYP 1, OCH DERAS ANVAENDNING SOM DIAGNOSTIKA OCH THERAPEUTIC MEDEL. Download PDF

Info

Publication number
FI883735L
FI883735L FI883735A FI883735A FI883735L FI 883735 L FI883735 L FI 883735L FI 883735 A FI883735 A FI 883735A FI 883735 A FI883735 A FI 883735A FI 883735 L FI883735 L FI 883735L
Authority
FI
Finland
Prior art keywords
och
maenniskans
immunbristsjukdom
antigener
diagnostika
Prior art date
Application number
FI883735A
Other languages
Finnish (fi)
Other versions
FI883735A0 (en
FI883735A7 (en
Inventor
Michael Broeker
Udo Krupka
Karl-Josef Abel
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI883735A0 publication Critical patent/FI883735A0/en
Publication of FI883735L publication Critical patent/FI883735L/en
Publication of FI883735A7 publication Critical patent/FI883735A7/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI883735A 1987-08-14 1988-08-11 Preparation and use of human immunodeficiency virus type 1 antigens as a diagnostic and therapeutic tool FI883735A7 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873727137 DE3727137A1 (en) 1987-08-14 1987-08-14 PRODUCTION OF ANTIGENS OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND THEIR USE AS A DIAGNOSTIC AGENT AND THERAPEUTIC

Publications (3)

Publication Number Publication Date
FI883735A0 FI883735A0 (en) 1988-08-11
FI883735L true FI883735L (en) 1989-02-15
FI883735A7 FI883735A7 (en) 1989-02-15

Family

ID=6333765

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883735A FI883735A7 (en) 1987-08-14 1988-08-11 Preparation and use of human immunodeficiency virus type 1 antigens as a diagnostic and therapeutic tool

Country Status (8)

Country Link
EP (1) EP0305777A3 (en)
JP (1) JPS6471488A (en)
KR (1) KR890003946A (en)
AU (1) AU2065488A (en)
DE (1) DE3727137A1 (en)
DK (1) DK454088A (en)
FI (1) FI883735A7 (en)
PT (1) PT88247A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2519296Y2 (en) * 1989-08-14 1996-12-04 株式会社ケンウッド Printed circuit board holding mechanism
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
ES2000858A6 (en) * 1985-08-12 1988-03-16 Syntex Inc A METHOD TO PRODUCE A BACTERIAL EXPRESSION VECTOR FOR THE EXPRESSION OF FUSION PROTEINS

Also Published As

Publication number Publication date
KR890003946A (en) 1989-04-19
EP0305777A3 (en) 1990-01-31
FI883735A0 (en) 1988-08-11
DE3727137A1 (en) 1989-02-23
JPS6471488A (en) 1989-03-16
PT88247A (en) 1989-06-30
AU2065488A (en) 1989-03-23
DK454088D0 (en) 1988-08-12
DK454088A (en) 1989-02-15
FI883735A7 (en) 1989-02-15
EP0305777A2 (en) 1989-03-08

Similar Documents

Publication Publication Date Title
FI862256L (en) GRUNDMJUKGOERARE SOM INNEHAOLLER KATJONISKT YTAKTIVT MEDEL OCH ORGANISK SYRA.
FI891689A7 (en) SOM ANTI-INFLAMMATORISKA OCH ANTIDEGENERATIVA MEDEL ANVAENDBARA NYA SUBSTITUERADE AZETIDINONER.
FI872299A0 (en) HETEROCYCLIS ANALOGER AV MEVALONOLAKTONER OCH DERAS DERIVAT, FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM PHARMACEUTISKA MEDEL.
FI891407A7 (en) ANORDNING FOER SVAELLNING AV NAERINGSAEMNEN, NJUTNINGS MEDEL OCH LIKNANDE.
FI922277A7 (en) ICKE-REPLICERANDE, MEDELST REKOMBINANT-TEKNIK FRAMSTAELLDA RETROVIRALA PARTIKLAR, VILKA ANVAENDES SOM ANTIVIRALA MEDEL OCH IMMUNOGENER.
FI885052L (en) KATALYSATORSYSTEM, SOM FOERHINDRAR BILDNING AV SVAVELVAETE OCH SOM INNEHAOLLER KOPPAROXID.
FI865233L (en) PYRAZOLINDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING SOM MEDEL MED INSEKTICID OCH AKARICID VERKAN.
FI871206A7 (en) 2-AZOLYLMETHYL-2-ARYL-1,3-DIOXOLANER OCH DERAS SALTER, FOERFARANDEN FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE MEDEL OCH DERAS ANVAENDNING.
FI871452L (en) FAERGLOESA KETIMINER, DERAS FRAMSTAELLNING OCH ANVAENDNING SOM FOERNAETNINGS MEDEL.
FI871955A7 (en) ANVAENDNING AV HETEROARYLETYLAMINER SOM PRESTATIONSBEFRAEMJANDE MEDEL HOS DJUR, HETEROARYLETYLAMINER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI870347A7 (en) NYA DIHYDROBENZOFURAN- OCH KROMANKARBOXIAMIDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM NEUROLEPTISKA MEDEL.
FI906139L (en) HALOGENERADE OLEFINER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA SOM SKADEDJURSBEKAEMPNINGS MEDEL.
FI883168A0 (en) 6,7-DIHYDRO-PYRAZOLE / 1,5-A / / 1,3,5 / TRIAZINE-2-SULPHONE SYRAMIDE
FI890721A7 (en) NYA KARBAMATER, DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM BRAENSLETILLSATS MEDEL.
FI891222A0 (en) ARYLPIPERAZINYLALKOXIDERIVAT AV CYCLISKA IMIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
FI863489A7 (en) FOERFARANDE OCH ANORDNING FOER AOTERVINNING AV I GASER BEFINTLIGA FOERORENINGAR, ISYNNERHET LOESNINGS MEDEL.
FI872827A0 (en) ANVAENDNING AV KARBOCYKLISKT OCH HETEROCYKLISKT KONDENSERADE DIHYDROPYRIDINER SOM KARDIOSKYDDANDE MEDEL OCH NYA HETEROCYKLISKT OCH KARBOCYKLISKT KONDENSERADE DIHYDROPYRIDINER, FOERFARER
FI910924L (en) NYA PROPANAMINER, FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA FOER THERAPEUTIC AENDAMAOL, I SYNNERHET SOM DIARREMEDICINER.
FI892207A0 (en) 2-ADAMANTYL-4-ISOTIAZOLINE-3-ONER, DERAS TILLVERKNINGSFOERFARANDE OCH ANVAENDNING SOM BAKTERICIDA OCH FUNGICIDA MEDEL.
FI883315A7 (en) 1H-PYRAZOL-1-ALKANAMIDER ANVAENDBARA SOM ANTIARRYTHMISKA MEDEL OCH DERAS FRAMSTAELLNING.
FI873852L (en) FOERENINGAR AV 2,3,4,5,6,7-HEXAHYDRO-2,7 -METHANOL-1,5-BENZOXAZONIN, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH LAEKEMEDEL, SOM INNEHAOLLER DESSA FOERENINGAR.
FI871207A7 (en) 2-AZOLYLMETHYL-2-ARYL-1,3-DIOXOLANER OCH DERAS SALTER, FOERFARANDEN FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE MEDEL OCH DERAS ANVAENDNING.
FI883183A7 (en) ANELLERADE IMINIAZOLER OCH IMINOAZINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM MEDEL MED HERBICID EFFEKT.
FI892289A7 (en) SUBSTITUERADE AZOLTIOETRAR, DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM SKADEDJURSBEKAEMPNINGS MEDEL.
FI883735L (en) FRAMSTAELLNING AV ANTIGENER AV MAENNISKANS IMMUNBRISTSJUKDOM, TYP 1, OCH DERAS ANVAENDNING SOM DIAGNOSTIKA OCH THERAPEUTIC MEDEL.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: BEHRINGWERKE AKTIENGESELLSCHAFT